A Swedish database of over 35,000 individuals found better cardiovascular outcomes when ezetimibe was added earlier to statin therapy for secondary prevention. Study authors deemed ezetimibe a ...

Please provide your email address to receive an email when new articles are posted on . It is well known that HMG-CoA reductase inhibitors reduce LDL, a surrogate marker in atherosclerotic disease, as ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — In a subgroup analysis of the IMPROVE-IT trial, which included patients with recent ACS on statin ...

May 19, 2011 (Charlottesville, Virginia) — Whereas statins appeared to halt atherosclerosis, ezetimibe (Zetia, Merck/Schering-Plough) was associated with an increase in plaque volume in peripheral ...

Ezetimibe is a lipid-lowering agent, prescribed for hypercholesterolemia. Cholestyramine can cause a decrease in the absorption of Ezetimibe resulting in a reduced serum concentration and potentially ...

Ezetimibe is a novel drug used for the inhibition of intestinal cholesterol absorption. It effectively reduces cholesterol absorption by approximately 54%, leading to ...

A recent simulation study published in the journal Scientific Reports analyzed representative data of over two million outpatients in Germany, in which the researchers reported that a combination of ...

Review the side-effects of Ezetimibe as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

The FDA has approved a new combination drug from Merck for lowering cholesterol. The drug, which will carry the brand name of Liptruzet, is a combination of two previously approved ...

A US Food and Drug Administration (FDA) advisory committee voted yesterday against approving a claim that adding ezetimibe, marketed as Zetia by Merck/Schering-Plough, to statin therapy reduces the ...

The US Food and Drug Administration has declined to extend the indication for the cholesterol-lowering drug ezetimibe to include cardiovascular event reduction, the manufacturer has announced. Merck ...

What to do: If your bottle of ezetimibe 10 mg tablets contains any perindopril 4 mg tablets, or if you are unsure, return it to your pharmacy immediately. If you are unable to return your tablets to ...